Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.

atypical CTC circulating tumor cells digital droplet PCR gene signature overall survival pancreatic cancer

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2019
Historique:
received: 12 06 2019
accepted: 22 08 2019
entrez: 26 9 2019
pubmed: 26 9 2019
medline: 26 9 2019
Statut: epublish

Résumé

The interest in liquid biopsy is growing because it could represent a non-invasive prognostic or predictive tool for clinical outcome in patients with pancreatic ductal adenocarcinoma (PDAC), an aggressive and lethal disease. In this pilot study, circulating tumor cells (CTCs), CD16 positive atypical CTCs, and CTC clusters were captured and characterized in the blood of patients with PDAC before and after palliative first line chemotherapy by ScreenCell device, immunohistochemistry, and confocal microscopy analysis. Gene profiles were performed by digital droplet PCR in isolated CTCs, five primary PDAC tissues, and three different batches of RNA from normal human pancreatic tissue. Welsh's

Identifiants

pubmed: 31552188
doi: 10.3389/fonc.2019.00874
pmc: PMC6746928
doi:

Types de publication

Journal Article

Langues

eng

Pagination

874

Références

Cancer Res. 2006 Mar 1;66(5):2778-84
pubmed: 16510599
Ann Surg Oncol. 2007 Dec;14(12):3629-37
pubmed: 17909916
Nature. 2007 Dec 20;450(7173):1235-9
pubmed: 18097410
Curr Mol Med. 2008 Dec;8(8):784-804
pubmed: 19075676
Br J Cancer. 2009 Aug 4;101(3):457-64
pubmed: 19603023
N Engl J Med. 2010 Apr 29;362(17):1605-17
pubmed: 20427809
J Surg Oncol. 2010 Jun 1;101(7):564-9
pubmed: 20461761
PLoS One. 2010 Nov 24;5(11):e14109
pubmed: 21124841
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Cell Mol Life Sci. 2011 Sep;68(18):3033-46
pubmed: 21637948
J Clin Oncol. 2011 Dec 1;29(34):4548-54
pubmed: 21969517
Br J Cancer. 2012 Jan 31;106(3):508-16
pubmed: 22187035
Nat Rev Cancer. 2012 Jan 12;12(2):133-43
pubmed: 22237392
Curr Pharm Des. 2013;19(5):940-50
pubmed: 22973962
BMC Cancer. 2012 Nov 16;12:527
pubmed: 23157946
Am J Gastroenterol. 2013 Jan;108(1):152-5
pubmed: 23287955
Pharmacol Ther. 2014 Feb;141(2):209-21
pubmed: 24134902
Cancers (Basel). 2011 Mar 24;3(2):1513-26
pubmed: 24212772
Tumour Biol. 2014 Mar;35(3):2473-80
pubmed: 24218336
Transl Oncol. 2013 Dec 01;6(6):649-59
pubmed: 24466367
PLoS One. 2014 Feb 19;9(2):e89474
pubmed: 24586805
Int J Cancer. 2015 Jun 1;136(11):2515-23
pubmed: 25111594
Clin Cancer Res. 2015 Feb 15;21(4):899-906
pubmed: 25516888
Pancreatology. 2015 Jan-Feb;15(1):8-18
pubmed: 25547205
Pancreas. 2015 May;44(4):547-50
pubmed: 25822154
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2900-9
pubmed: 25991856
J Oral Pathol Med. 2016 Mar;45(3):180-8
pubmed: 26399460
Ann Surg. 2016 Dec;264(6):1073-1081
pubmed: 26756760
Clin Chem. 2016 Mar;62(3):505-13
pubmed: 26861552
Cancer Biomark. 2016 Mar 4;16(4):513-21
pubmed: 27062566
Br J Cancer. 2016 Jun 14;114(12):1367-75
pubmed: 27300108
Biochem Biophys Res Commun. 2016 Sep 2;477(4):568-574
pubmed: 27320862
Oncotarget. 2016 Jul 19;7(29):45876-45888
pubmed: 27322682
Anticancer Res. 2017 Jan;37(1):169-173
pubmed: 28011487
Med Oncol. 2017 Jan;34(1):12
pubmed: 28012133
Urol Oncol. 2017 May;35(5):300-309
pubmed: 28202223
Dis Markers. 2017;2017:3414910
pubmed: 28321147
Int J Mol Sci. 2017 Apr 06;18(4):
pubmed: 28383487
Med Sci Monit. 2017 Jun 14;23:2897-2905
pubmed: 28611349
Br J Cancer. 2017 Nov 21;117(11):1583-1591
pubmed: 29065107
Oncotarget. 2017 Jul 18;8(47):82326-82343
pubmed: 29137267
Acta Histochem. 2018 Apr;120(3):302
pubmed: 29598902
Eur J Surg Oncol. 2018 Jun;44(6):860
pubmed: 29605162
Diagnostics (Basel). 2018 Apr 11;8(2):null
pubmed: 29641512
Anal Cell Pathol (Amst). 2018 Mar 7;2018:9718585
pubmed: 29707475
Sci Adv. 2018 Sep 12;4(9):eaat7828
pubmed: 30214939
Aging Cell. 2019 Apr;18(2):e12889
pubmed: 30614183
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
World J Gastroenterol. 2019 Jan 7;25(1):138-150
pubmed: 30643364
Ginekol Pol. 2019;90(1):11-19
pubmed: 30756366
World J Oncol. 2019 Feb;10(1):10-27
pubmed: 30834048

Auteurs

Consuelo Amantini (C)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.

Maria Beatrice Morelli (MB)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
School of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.

Massimo Nabissi (M)

School of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.

Francesco Piva (F)

Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, Ancona, Italy.

Oliviero Marinelli (O)

School of Biosciences and Veterinary Medicine, University of Camerino, Camerino, Italy.
School of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.

Federica Maggi (F)

Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy.

Francesca Bianchi (F)

Oncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.

Alessandro Bittoni (A)

Oncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.

Rossana Berardi (R)

Oncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.

Riccardo Giampieri (R)

Oncology Clinic, AOU Ospedali Riuniti, Polytechnic University of Marche, Ancona, Italy.

Giorgio Santoni (G)

School of Pharmacy, Experimental Medicine Section, University of Camerino, Camerino, Italy.

Classifications MeSH